Baidu
map

CDH22 hypermethylation is an independent prognostic biomarker in breast cancer

Martin-Sanchez, E; Mendaza, S; Ulazia-Garmendia, A; Monreal-Santesteban, I; Cordoba, A; Vicente-Garcia, F; Blanco-Luquin, I; De La Cruz, S; Aramendia, A; Guerrero-Setas, D

Martin-Sanchez, E; Guerrero-Setas, D (reprint author), UPNA, IdiSNA, Navarrabiomed Dept Salud, Canc Epigenet Grp, Irunlarrea Rd 3, Pamplona 31008, Spain.; Guerrero-Setas, D (reprint author), Complejo Hosp Navarra, Dept Pathol, Irunlarrea Rd 3, Pamplona 31

Clinical Epigenetics, 2017; 9 ( ):

Baidu
map
Baidu
map
Baidu
map